Osteoporosis is a systemic skeletal disorder leading to decreased bone mineralisation and a
propensity for fracture. The disease affects millions of people and is a source of significant …

Introduction: Osteoporotic fractures represent a growing burden of mortality, morbidity and
socioeconomic cost to health-care systems worldwide. Osteoporosis is a disease uniquely …

Osteoporosis is a silent disease with increasing prevalence due to the global ageing
population. Decreased bone strength and bone quality is the hallmark of osteoporosis which …

Osteoporosis, a common chronic metabolic bone disease is associated with considerable
morbidity and mortality. As the prevalence of osteoporosis increases with age, a paralleled …

The prevalence of osteoporosis in a large population is a social burden globally. Generally,
early diagnosis and treatments can improve the clinical therapeutic outcomes in the clinic …

Written by a world-recognised expert in the field of osteoporosis, who has published
extensively, and is recognized as a key opinion leader. Aimed at primary care physicians …

In 1970, there were no drugs under study for osteoporosis. Estrogen was used, but little was
known about the correct dose for preventing bone loss. At that time, fractures were not even …

In recent decades, osteoporosis has evolved from being viewed as an inevitable
consequence of ageing to becoming a recognised disease, with a diagnostic definition …

Osteoporotic fracture is a major cause of morbidity in older people. For example, in the
United States there are over one million fractures related to diminished bone density each …

Conclusions The incidence of osteoporosis has increased over the last 30 years, and is
expected to continue to increase into the next century. Drug treatment for this condition has …